The global urinary incontinence devices market size was valued at $2,098.65 million in 2020, and is projected to reach $6,179.32 million by 2030, registering a CAGR of 11.8% from 2021 to 2030. Any ...

The implantable Axonics SNS (sacral neuromodulation system) device treats overactive bladder – a common cause ... patient to activate the stimulator, control the strength of impulses, and ...

As the population ages, the number of people suffering from bladder control problems is increasing. The costs of this problem are personal, physical and financial, and many with incontinence suffer ...

To assess outcomes, changes from baseline in overactive bladder syndrome (OAB) symptoms on voiding diaries and patient-reported outcomes were collected after 8 and 12 weeks of treatment. The eCoin™ ...